CAS 501935-96-2

Formula: C14H10N4

InChI: InChI=1S/C14H10N4/c15-7-12-10-3-1-8(16)5-13(10)18-14-6-9(17)2-4-11(12)14/h1-6H,16-17H2

InChI key: PUMGFEMNXBLDKD-UHFFFAOYSA-N

SMILES: C1=CC2=C(C=C1N)N=C3C=C(C=CC3=C2C#N)N

CTX1

CAS: 501935-96-2

CTX1

Formula: C₁₄H₁₀N₄

Purity: 97.02%

Molecular weight: 234.26

Ref: 54-OR1130728

CTX1

CAS: 501935-96-2

Formula: C₁₄H₁₀N₄

Purity: 97.02%

Molecular weight: 234.256

Ref: IN-DA00DMMG

CTX1

CAS: 501935-96-2

Formula: C₁₄H₁₀N₄

Molecular weight: 234.26

Ref: 4Z-C-353001

CTX1-d6

CAS: 501935-96-2

Formula: C₁₄H₄D₆N₄

Molecular weight: 240.30

Ref: 4Z-C-353002

CTX1

CAS: 501935-96-2

Formula: C₁₄H₁₀N₄

Molecular weight: 234.26

Ref: BE-RMCC389001

CTX1

CAS: 501935-96-2

CTX1 is a novel protease inhibitor that has been shown to inhibit collagen-induced arthritis in mice. CTX1 also inhibits the activity of matrix metalloproteinases (MMPs) and their related proteinases, which are key enzymes responsible for the degradation of bone and cartilage. CTX1 may be used as a therapeutic agent in the treatment of joint diseases that involve MMPs, such as rheumatoid arthritis. CTX1 is also an anti-oxidant agent that can protect cells from oxidative stress. The enzyme activity index for CTX1 was found to be 10 times higher than for other protease inhibitors. This high protease activity is correlated with its ability to inhibit growth factor-β1, which is involved in the regulation of cell proliferation and differentiation. CTX1 can also prevent abdominal surgery-induced weight gain by inhibiting the production of pro-inflammatory cytokines from adipose tissue.

Formula: C₁₄H₁₀N₄

Purity: Min. 95%

Molecular weight: 234.26 g/mol

Ref: 3D-BVA93596

CTX1

CAS: 501935-96-2

CTX1 is a p53 activator that binds HdmX to block p53 interaction in a DNA damage-independent manner for AML research.

Formula: C₁₄H₁₀N₄

Purity: 99.42%

Color and Shape: Solid

Molecular weight: 234.256

Ref: TM-T15016